Treace Medical Concepts Inc stock is traded at $4.31, with a volume of 232,753. It is down -0.92% in the last 24 hours and up +5.90% over the past month. Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities. The company's patented Lapiplasty 3D Bunion Correction procedure is designed to reproducibly correct all planes of the bunion deformity and address the root cause of the bunion, while allowing patients to return to their active lives quickly. The company operates and manages its business as a single segment: designing, manufacturing, and marketing medical devices for surgeons, ambulatory surgery centers, and hospitals related to the surgical management of bunion and related midfoot deformities.
Previous Close:
$4.35
Open:
$4.31
24h Volume:
232,753
Relative Volume:
0.56
Market Cap:
$282.56M
Revenue:
$207.32M
Net Income/Loss:
-$61.04M
P/E Ratio:
-
EPS:
-$0.9577
Net Cash Flow:
-$25.97M
1W Performance:
-18.22%
1M Performance:
+5.90%
6M Performance:
+52.84%
1Y Performance:
+65.13%
1-Day Range:
$4.17$4.43
1-Week Range:
$4.17$5.36
52-Week Range:
$1.17$5.44
Treace Medical Concepts Inc Stock (TMCI) Company Profile
Name
Treace Medical Concepts IncSector
HealthcareIndustry
Medical DevicesPhone
(904) 373-5940Address
100 PALMETTO PARK PLACE, PONTE VEDRA, USAMarket Cap
Revenue
Net Income
Cash Flow
EPS